Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 13;9(11):1683.
doi: 10.3390/biomedicines9111683.

Wnt/β-Catenin Pathway in Experimental Model of Fibromyalgia: Role of Hidrox®

Ramona D'Amico  1 , Marika Cordaro  2 , Rosalba Siracusa  1 , Daniela Impellizzeri  1 , Angela Trovato Salinaro  3 , Maria Scuto  3 , Maria Laura Ontario  3 , Roberto Crea  4 , Salvatore Cuzzocrea  1 , Rosanna Di Paola  1 , Roberta Fusco  1 , Vittorio Calabrese  3
Affiliations

Wnt/β-Catenin Pathway in Experimental Model of Fibromyalgia: Role of Hidrox®

Ramona D'Amico et al. Biomedicines. .

Abstract

Fibromyalgia (FM) is a chronic condition characterized by persistent widespread pain that negatively affects the quality of life of patients. The WNT/β-catenin signaling pathway seems to be involved in central sensitization and different pain states. The objective of this study was to investigate the beneficial effects of a new compound called Hidrox® (HD), containing 40-50% hydroxytyrosol, in counteracting the pain associated with FM. An FM-like model was induced in rats by subcutaneous injections of reserpine (1 mg/kg) for three consecutive days. Later, HD (10 mg/kg) was administered orally to the animals for seven days. Reserpine injections induced WNT/β-catenin pathway activation, release of pro-inflammatory mediators as well as a significant increase in oxidative stress. Daily treatment with HD was able to modulate the WNT/β-catenin and Nrf2 pathways and consequently attenuate the behavioral deficits and microglia activation induced by reserpine injection. These results indicate that nutritional consumption of HD can be considered as a new therapeutic approach for human FM.

Keywords: Nrf2 pathway; WNT/β-catenin pathway; fibromyalgia; pain.

PubMed Disclaimer

Conflict of interest statement

Roberto Crea is the president of Oliphenol LLC. and owns a patent for the Hidrox compound. The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Effect of HD on WNT/FZ/β-catenin signaling pathway: Western blot analysis of Wnt-3a (A), FZ8 (B), cytosolic β-catenin (C) and nuclear β-catenin (D) expression. *** p < 0.001 vs. sham; ### p < 0.001 vs. vehicle.
Figure 2
Figure 2
Effect of HD on pro-inflammatory cytokines levels: ELISA assay of IL-18 (A) TNF-α (B) and IL-1β (C) *** p < 0.001 vs. sham; ### p < 0.001 vs. vehicle.
Figure 3
Figure 3
Effect of HD on mechanical and thermal hyperalgesia: von Frey hair (A) hot plate (B) and tail-flick warm water (C) tests. * p < 0.05 vs. sham; ** p < 0.01 vs. sham; *** p < 0.001 vs. sham; # p < 0.05 vs. vehicle; ## p < 0.01 vs. vehicle.
Figure 4
Figure 4
Effect of HD on microglia activation and BDNF expression: immunohistochemical evaluation in the spinal cord for Iba1 expression: Sham (A), Vehicle (B), Vehicle + HD (C) and BDNF expression: Sham (D), Vehicle (E), Vehicle + HD (F). Graphical quantification of Iba1 (G) and BDNF expression (H). The black arrows indicated positive cells. A 40× magnification is shown (75-µm scale bar). *** p < 0.001 vs. sham; ### p < 0.001 vs. vehicle.
Figure 5
Figure 5
Effect of HD on oxidative stress: Western blot analysis of Nrf2 (A), HO-1 (B), NQQO-1 (C) expression. * p < 0.05 vs. sham; ** p < 0.01 vs. sham; ### p < 0.001 vs. vehicle.
See this image and copyright information in PMC

References

    1. Siracusa R., Paola R.D., Cuzzocrea S., Impellizzeri D. Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update. Int. J. Mol. Sci. 2021;22:3891. doi: 10.3390/ijms22083891. - DOI - PMC - PubMed
    1. De la Luz-Cuellar Y.E., Rodriguez-Palma E.J., Franco-Enzastiga U., Salinas-Abarca A.B., Delgado-Lezama R., Granados-Soto V. Blockade of spinal alpha5-GABAA receptors differentially reduces reserpine-induced fibromyalgia-type pain in female rats. Eur. J. Pharmacol. 2019;858:172443. doi: 10.1016/j.ejphar.2019.172443. - DOI - PubMed
    1. D’Amico R., Impellizzeri D., Cuzzocrea S., Di Paola R. ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain. Int. J. Mol. Sci. 2020;21:5330. doi: 10.3390/ijms21155330. - DOI - PMC - PubMed
    1. Jensen K.B., Loitoile R., Kosek E., Petzke F., Carville S., Fransson P., Marcus H., Williams S.C., Choy E., Mainguy Y., et al. Patients with fibromyalgia display less functional connectivity in the brain’s pain inhibitory network. Mol. Pain. 2012;8:32. doi: 10.1186/1744-8069-8-32. - DOI - PMC - PubMed
    1. Fusco R., Siracusa R., D’Amico R., Peritore A.F., Cordaro M., Gugliandolo E., Crupi R., Impellizzeri D., Cuzzocrea S., Di Paola R. Melatonin Plus Folic Acid Treatment Ameliorates Reserpine-Induced Fibromyalgia: An Evaluation of Pain, Oxidative Stress, and Inflammation. Antioxidants. 2019;8:628. doi: 10.3390/antiox8120628. - DOI - PMC - PubMed

LinkOut - more resources